Gastric cancer is a common malignant tumor of digestive tract tumors. TLR4 is a natural immune cell regulator. In recent years, the molecular mechanism and prevention and treatment of TLR4-related pathways affecting the progression of gastric cancer have become a hot topic. This paper reviews TLR4 and its related signaling pathways, the correlation between TLR4-related pathways and gastric cancer, and the regulation of TLR4-related signaling pathways in the treatment of gastric cancer, in order to provide more evidence for new approaches to treat gastric cancer in the future.

Hua Li, Jiehong Wang. Research progress in cancer treatment based on TLR4 related genes. Academic Journal of Medicine & Health Sciences (2023) Vol. 4, Issue 6: 71-76. https://doi.org/10.25236/AJMHS.2023.040611.

[1] Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer[J]. Lancet, 2020, 396(10251): 635-648. 

[2] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.

[3] Sano T. Gastric cancer: Asia and the world[J]. Gastric Cancer, 2017, 20(Suppl 1): 1-2. 

[4] Chen WQ, Li H, Sun KX, et al. Report of Cancer Incidence and Mortality in China, 2014[J]. Zhonghua Zhong Liu Za Zhi, 2018, 40(1): 5-13. 

[5] Tongtawee T, Simawaranon T, Wattanawongdon W, et al. Toll-like receptor 2 and 4 polymorphisms associated with Helicobacter pylori susceptibility and gastric cancer[J]. Turk J Gastroenterol, 2019, 30(1): 15-20. 

[6] Karimi P, Islami F, Anandasabapathy S, et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention [J]. Cancer Epidemiol Biomarkers Prev, 2014, 23(5): 700-713. 

[7] Yang Ying, Hou Tingting, Wang Wei, Chen Yanjun, Liu Dong. Research progress on pharmacological effects of polysaccharides from Polygonati Rhizoma [J]. Drugs & Clinic, 2022, 37(3): 659-665. 

[8] Lazăr DC, Tăban S, Cornianu M, et al. New advances in targeted gastric cancer treatment[J]. World J Gastroenterol, 2016, 22(30): 6776-6799.

[9] Zeng D, Li M, Zhou R, et al. Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures[J]. Cancer Immunol Res, 2019, 7(5): 737-750.

[10] Chen Junli, Pei Ming, Zhou Haokun, et al. Research progress of Toll-like receptor 4 signaling pathway in fibrosis[J]. Hebei Medical Journal, 2022, 44(13): 2044-2048. 

[11] Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway[J]. Cytokine, 2008, 42(2): 145-151.  

[12] Zou Xinmei, Wang Yang, Zhong Liping. Clinical significane of TLR2 and TLR4 expression in Helicobacter pylori infection-related gastric cancer tissues[J]. Zhejiang Journal of Integrated Traditional Chinese and Western Medicine, 2022, 32(2): 136-139. 

[13] Li Z, Gao H, Liu Y, et al. Genetic variants in the regulation region of TLR4 reduce the gastric cancer susceptibility [J]. Gene, 2021, 767: 145181. 

[14] Zhang Yameng, Zhang Yueying, Xiang Hongjie. The Role of TLR4/NF-кB Pathway in Hp Induced Gastric Cancer[J].World Journal of Integrated Traditional and Western Medicine, 2019, 14(12): 1691-1694.

[15] Hu Chenghao, Luo Qingqin, Zhang Danfeng, et al. Expression of Toll-like receptor 4 in gastric cancer and its clinical significance[J]. Chinese Journal of Clinical Research, 2018, 31(4): 459-462. 

[16] Wang Yang, Zou Xinmei, Pan Qinmei, et al. Clinical significance of changes of TLR4/ MyD88/ NF-κB signaling pathway in peripheral blood mononuclear cells of gastric cancer patients with Helicobacter pylori infection[J]. World Chinese Journal of Digestology, 2021, 29(6): 319-324. 

[17] Newton K, Dixit VM. Signaling in innate immunity and inflammation[J]. Cold Spring Harb Perspect Biol, 2012, 4(3): a006049. 

[18] Hishida A, Matsuo K, Goto Y, et al. Toll-like receptor 4 +3725 G/C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese[J]. Helicobacter, 2009, 14(1): 47-53. 

[19] Santini D, Angeletti S, Ruzzo A, et al. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes[J]. Clin Exp Immunol, 2008, 154(3): 360-364. 

[20] Kang Zhenchao, Li Xiao, Zhu Xiaomei, et al. Ophiopogonin D inhibits the secretion of cytokines from LPS-induced gastric cancer cell line HGC-27 by regulating miR-448/TLR4 axis[J]. Chinese Journal of Immunology, 2022, 38(5): 416-423. 

[21] Geng Jing, Zhang Shuxian, Sun Yunliang. Triptolide enhances the sensitivity of gastric cancer BGC823 cells to 5-FU by suppressing TLR4 expression [J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2022, 30(4): 263-267.

[22] Zhong Chan, Zhang Tao, Huang LiBingbing, et al. Effects of Qingrehuashifang on levels of TNF-α, IL-8 and TLR-4 in gastric tissue of mice infected with MNU and Helicobacter pylori[J]. Chinese Traditional Patent Medicine, 2020, 42(5): 1339-1343. 

[23] Yi Qingting, Zhang Hongjun, Jiang Tao, et al. Reversal effect and mechanism of polyene phosphatidylcholine on oxaliplatin resistance of gastric cancer cells in a nude mouse model[J]. Practical Oncology Journal, 2018, 32(5): 385-390. 

[24] Wang Xue, Ling Jiayin, Zhai Yongcong, et al. Effects of total Flavonoids of Hedyotis diffusa on serum tumor markers and immune function of MFC gastric cancer bearing mice[J]. The Chinese Journal of Clinical Pharmacology, 2021, 37(19): 2627-2630. 

[25] Lv Pintian, Duan Xinbo. Antitumor and immunomodulatory effects of Polygonatum polygonatum polysaccharide on MFC gastric cancer mice[J]. Chinese Traditional Patent Medicine, 2020, 42(8): 2169-2172. 

[26] Lei Shengping, Wang Liang, Long Zijiang, et al. Inhibitory effect of Polygonatum sibiricum polysaccharides on release of inflammatory cytokines of anoxia/reoxygenation H9c2 myocardial cells through TLR4-MyD88-NF-κB signaling pathway[J]. Chinese Pharmacological Bulletin, 2017, 33(2): 255-259, 260.

[27] Wang Juanyi, Liu Zhongqiu, Li Wei, et al. Matrine alleviates N-methyl-N '-nitro-n- nitrosoguanidine (MNNG) -induced gastric mucosal injury in rats and its mechanism[J]. Chinese Journal of Cellular and Molecular Immunology, 2020, 36(2): 157-163.

[28] Zhang M L. Study on the therapeutic effect and mechanism of Jianpi Huoxui Formula in the treatment of atrophic gastritis accompanied by precancerous lesions based on TLR4 pathway [D]. Wuhan: Hubei University of Traditional Chinese Medicine, 2021. 

[29] Wu Qi, Wang Hongwei, Zheng Huizhe, et al. Effect of HMGB1 expression on invasion and migration of gastric cancer cells and TLR4/MyD88/NF-κB signaling pathway[J]. Journal of Guizhou Medical University, 2021, 46(9): 1047-1053.

[30] Yang Zihao, Zhou Henglu. Effects of Codonopsis pilosum polysaccharide on the proliferation, apoptosis and expression of inflammatory factors in gastric cancer cells AGS by regulating miR-361-5p/TLR4/NF-κB pathway [J]. Chinese Journal of Immunology, 2022, 38(4): 347-353.

[31] Zhou Anfu, Tan Yan, Zhang Huijing. Gastric cancer exosome lncRNA CASC11 regulates TLR4/ NF-κB pathway to induce polarization of M2-type macrophages[J].Hebei Medicine, 2021, 27(12): 1948-1957. 

[32] Zhang Dan, Wang Yunye. Anti-tumor effect and immunological mechanism of lactobacillus casei in a rat model of gastric cancer[J]. Chinese Journal of Comparative Medicine, 2018, 28(12): 48-54.